Global Postpartum Hemorrhage (PPH) Devices Market 2018-2022
About Postpartum Hemorrhage (PPH) Devices
PPH is defined as blood loss of more than 500 ml from the genital tract within 24 hours of the vaginal birth of a baby, or 1,000 ml or more after a cesarean delivery. PPH devices are the equipment that is used to manage or limit the uterine blood loss during PPH.
Technavio’s analysts forecast the global postpartum hemorrhage (PPH) devices market to grow at a CAGR of 5.22% during the period 2018-2022.
Covered in this report
The report covers the present scenario and the growth prospects of the global postpartum hemorrhage (PPH) devices market for 2018-2022. To calculate the market size, the report presents a detailed picture of the market by way of study, synthesis, and summation of data from multiple sources.
The market is divided into the following segments based on geography:
Technavio Announces the Publication of its Research Report – Global Postpartum Hemorrhage (PPH) Devices Market 2018-2022
Technavio recognizes the following companies as the key players in the global postpartum hemorrhage (PPH) devices market: BD, Cook Medical, C. R. Bard, Teleflex, Utah Medical Products, and ZOEX.
Commenting on the report, an analyst from Technavio’s team said: “One trend in the market is increasing focus on development of alternative PPH treatment devices. Many vendors are increasingly focusing on the development of novel PPH devices. For instance, in April 2017, Clinical Innovations launched its ebb Complete Tamponade System (PPH balloon) for PPH. It allows for rapid, emergency deployment to minimize or eliminate bleeding in more than 95% of the cases.”
According to the report, one driver in the market is increasing incidence of PPH. The incidence of PPH is increasing globally. PPH is the leading cause of maternal mortality. It is one of the top five causes of maternal mortality in both high and low per capita income countries. In 2016, it was estimated that globally, four out of every ten maternal deaths resulted from two causes, namely, PPH and pre-eclampsia/eclampsia. Every year, approximately, 15 million women suffer from PPH globally.
Further, the report states that one challenge in the market is dearth of maternity healthcare services in developing countries. A severe shortage of resources for the treatment of PPH is observed in developing countries. This is particularly acute in the countries of Africa and Asia where PPH is the leading cause of maternal mortality. More than 95% of the world's annual maternal deaths occur in developing countries. Most of the developing countries lack experienced caregivers who are trained to manage PPH successfully.
BD, Cook Medical, C. R. Bard, Teleflex, Utah Medical Products, and ZOEX.